Apollo Gleneagles Cancer Hospital
Kolkata, West Bengal, India
Hospital in Kolkata, West Bengal
51, Kadapara, Phool Bagan, Kankurgachi, Kolkata, West Bengal 700054
About Apollo Gleneagles Cancer Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Apollo Gleneagles Cancer Hospital
During the past decade, Apollo Gleneagles Cancer Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
2003-06-01
2006-12-01
Completed
440
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
2006-09-01
2009-08-01
Completed
849
Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)
2007-01-01
2015-04-01
Completed
1,513
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
2005-12-01
2008-04-01
Terminated
165
Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
2007-09-01
2009-10-01
Terminated
153
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
2013-06-27
2020-11-12
Completed
2,877
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Apollo Gleneagles Cancer Hospital"
#1 collaborator was "Merck Ltd., India" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Apollo Gleneagles Cancer Hospital
According to Clinical.Site data, the most researched conditions in "Apollo Gleneagles Cancer Hospital" are
"Carcinoma, Squamous Cell" (1 trials), "Colorectal Neoplasms" (1 trials), "LA SCCHN" (1 trials) and "Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck" (1 trials). Many other conditions were trialed in "Apollo Gleneagles Cancer Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Apollo Gleneagles Cancer Hospital
Most popular intervention types in "Apollo Gleneagles Cancer Hospital" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Cetuximab" (2 trials) and "Cetuximab + RT" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Apollo Gleneagles Cancer Hospital
The vast majority of trials in "Apollo Gleneagles Cancer Hospital" are
3 trials for "All" genders.
Clinical Trials Status at Apollo Gleneagles Cancer Hospital
Currently, there are NaN active trials in "Apollo Gleneagles Cancer Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Apollo Gleneagles Cancer Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Apollo Gleneagles Cancer Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".